Identifying chemical changes is a cornerstone of understanding these transformations, and it's crucial to differentiate them ...

About ORLADEYO® (berotralstat) ORLADEYO ® (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 ...

Congress failed to reach a funding deal by the Wednesday, Oct. 1, deadline, leading to a government shutdown that will force active-duty service members to continue to serve without pay until a deal ...

Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that the Company will present 11 abstracts, including a late-breaking poster, at the upcoming American Society of Nephrology (ASN) Kidney Week ...